- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
12 result(s) found for: Cell Surface Marker.
Displaying page 1 of 1.
EudraCT Number: 2006-000985-34 | Sponsor Protocol Number: 001:CD40L | Start Date*: 2006-06-15 |
Sponsor Name:Clinical Immunology Division | ||
Full Title: A Phase I-IIa Study of Dose escalating Intravesical AdCD40L instillation in Urinary Bladder Carcinoma | ||
Medical condition: Urinary bladder cancer is an attractive target for immunostimulating gene therapy because it is sensitive for immunotherapy as demonstrated by the life-prolonging effect of bacillus Calmette-Guérin... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-017525-19 | Sponsor Protocol Number: 77777 | Start Date*: 2010-03-12 |
Sponsor Name:St. Vincents University Hospital, Department of Rheumatology. | ||
Full Title: Abatacept in Psoriasis and Psoriatic Arthritis: a single centre, placebo-controlled, crossover study in 15 patients. | ||
Medical condition: Psoriatic Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003202-16 | Sponsor Protocol Number: PB/0046 | Start Date*: 2015-10-20 |
Sponsor Name:Academic Medical Centre | ||
Full Title: A randomized, double-blind, placebo-controlled study to compare the safety and immune effects of multiple doses of vitamin D3 in patients with allergic rhinitis/rhino-conjunctivitis caused by birc... | ||
Medical condition: subcutaneous immunotherapy in allergic rhinits (AR) patients with allergies to birchpollen | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-014593-18 | Sponsor Protocol Number: CT-2008-01 | Start Date*: 2009-12-07 | |||||||||||
Sponsor Name:CureTech | |||||||||||||
Full Title: CT-2008-01: Phase II study to evaluate the safety, tolerability and efficacy of FOLFOX + CT-011 versus FOLFOX alone administered intravenously to patients with colorectal adenocarcinoma previously ... | |||||||||||||
Medical condition: This study will enroll patients with untreated, metastatic colorectal carcinoma who are eligible for first line FOLFOX therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018331-18 | Sponsor Protocol Number: ML25243 | Start Date*: 2010-05-12 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd. | |||||||||||||
Full Title: A 52 week, Single center, Open-label Study to Evaluate Neutrophil function and survival effects of Tocilizumab (TCZ) in Patients with Active Rheumatoid Arthritis (RA) on Background Non-biologic DMA... | |||||||||||||
Medical condition: Adult Rheumatoid Arthritis (RA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003930-17 | Sponsor Protocol Number: 1407-GUCG | Start Date*: 2015-10-05 | |||||||||||
Sponsor Name:European Organisation for Research and Treatment of Cancer (EORTC) | |||||||||||||
Full Title: A RANDOMIZED PHASE III TRIAL COMPARING CONVENTIONAL-DOSE CHEMOTHERAPY USING PACLITAXEL, IFOSFAMIDE, AND CISPLATIN (TIP) WITH HIGH-DOSE CHEMOTHERAPY USING MOBILIZING PACLITAXEL PLUS IFOSFAMIDE FOLLO... | |||||||||||||
Medical condition: progressive or recurrent germ cell tumor (measurable or non-measurable) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: BE (Ongoing) DK (Ongoing) IE (Ongoing) FR (Ongoing) NL (Ongoing) SI (Completed) ES (Ongoing) DE (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001789-13 | Sponsor Protocol Number: 2016/02 | Start Date*: 2020-01-13 | ||||||||||||||||
Sponsor Name:Clinical Trials and Research Governance (CTRG), University of Oxford | ||||||||||||||||||
Full Title: A randomised, open label study, exploring the differences in immunogenicity and reactogenicity of infants after immunisation with either an acellular (aP) or whole cell pertussis (wP) vaccine | ||||||||||||||||||
Medical condition: This study is going to focus on the immunisations against pertussis disease in previous healthy children, but the disease itself is not going to be study. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005220-26 | Sponsor Protocol Number: ACE-LY-308 | Start Date*: 2017-05-16 | |||||||||||
Sponsor Name:Acerta Pharma BV | |||||||||||||
Full Title: A Phase 3, Randomized, Double blind, Placebo controlled, Multicenter Study of Bendamustine and Rituximab (BR) alone Versus in Combination with Acalabrutinib (ACP 196) in Subjects with Previously Un... | |||||||||||||
Medical condition: Mantle Cell Lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) DE (Ongoing) BE (Ongoing) ES (Ongoing) CZ (Ongoing) GR (Ongoing) PL (Ongoing) FR (Ongoing) IT (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005178-43 | Sponsor Protocol Number: OMB115991 | Start Date*: 2012-02-08 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A Phase II, Multi-centre Study Investigating the Safety and Efficacy of Ofatumumab and Bendamustine Combination in Patients with Untreated or Relapsed Chronic Lymphocytic Leukaemia (CLL) | |||||||||||||
Medical condition: Untreated or Relapsed Chronic Lymphocytic Leukaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Prematurely Ended) BE (Completed) ES (Completed) PL (Completed) GR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004050-16 | Sponsor Protocol Number: HEAT-AML | Start Date*: 2019-08-01 | |||||||||||
Sponsor Name:University Hospital Karolinska | |||||||||||||
Full Title: HEAT-AML (Hydroxyurea-Enhanced Ara-C Treatment of Adult Acute Myeloid Leukaemia): A phase I/II multicenter study to assess the tolerability and efficacy of the addition of hydroxyurea to standard a... | |||||||||||||
Medical condition: Newly diagnosed acute myeloid leukaemia (AML) in patients ≥ 18 years of age | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001984-35 | Sponsor Protocol Number: M16OPN | Start Date*: 2017-06-22 | |||||||||||
Sponsor Name:Antoni van leeuwenhoek ziekenhuis | |||||||||||||
Full Title: Multicenter Phase 2 Study to Identify of the Optimal neo-Adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN-neo) | |||||||||||||
Medical condition: Patients with stage III melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) AT (Prematurely Ended) GB (GB - no longer in EU/EEA) DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002125-19 | Sponsor Protocol Number: 9494 | Start Date*: 2016-06-20 |
Sponsor Name:CHU MontpellierCentre administratif André Benech, | ||
Full Title: A phase IIb, prospective, multicentre, double-blind, triple-arm, randomized versus placebo trial, to assess the efficacy of a single injection of either 2 or 10 x 106 autologous adipose derived mes... | ||
Medical condition: Active knee Osteoarthritis (mild to moderate) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) NL (Completed) DE (Completed) IE (Completed) GB (GB - no longer in EU/EEA) FR (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.